Dr. Sheryle Rogerson is a dedicated Neonatologist at The Royal Women's Hospital, where she plays a pivotal role in enhancing the care of newborn infants. With a specialized focus on the application of ultrasound (USS) in both diagnostic and clinical settings, Dr. Rogerson is committed...
Dr. Sheryle Rogerson is a dedicated Neonatologist at The Royal Women's Hospital, where she plays a pivotal role in enhancing the care of newborn infants. With a specialized focus on the application of ultrasound (USS) in both diagnostic and clinical settings, Dr. Rogerson is committed to improving patient outcomes in the Neonatal Intensive Care Unit (NICU). Her expertise in functional ultrasound allows her to guide treatment decisions with precision, ensuring that each infant receives tailored care based on their unique medical needs.
In her current role, Dr. Rogerson is actively involved in teaching ultrasound techniques to fellow neonatologists, fostering a culture of continuous learning and innovation within the Neonatal Unit. By equipping her colleagues with advanced skills in ultrasound, she aims to elevate the standard of care for all neonatal patients. Her passion for education is complemented by her position as a board member of the Australian Society of Ultrasound Medicine, where she contributes to the advancement of ultrasound practices in the field.
Dr. Rogerson’s clinical research efforts focus on the integration of ultrasound technology in critical care settings, exploring its potential to enhance patient safety and treatment efficacy. Her comprehensive skill set encompasses not only neonatology and critical care but also a deep understanding of diagnostic ultrasound, making her a valuable asset to both her patients and the broader medical community. Through her work, she continues to advocate for the use of innovative diagnostic tools to improve the health and well-being of vulnerable newborns.
